Spatiotemporal gait parameters and plantar pressure distribution during barefoot walking in people with gout and asymptomatic hyperuricemia: comparison with healthy individuals with normal serum urate concentrations
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-1146
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Spatiotemporal gait parameters and plantar pressure distribution during barefoot walking in people with gout and asymptomatic hyperuricemia: comparison with healthy individuals with normal serum urate concentrations ; volume:9 ; number:1 ; day:30 ; month:4 ; year:2016 ; pages:1-9 ; date:12.2016
Journal of foot and ankle research ; 9, Heft 1 (30.4.2016), 1-9, 12.2016
- Creator
-
Stewart, Sarah
- Contributor
-
Dalbeth, Nicola
Vandal, Alain C.
Rome, Keith
SpringerLink (Online service)
- DOI
-
10.1186/s13047-016-0147-4
- URN
-
urn:nbn:de:1111-201605041350
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Stewart, Sarah
- Dalbeth, Nicola
- Vandal, Alain C.
- Rome, Keith
- SpringerLink (Online service)
Other Objects (12)
Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2
Adherence with urate-lowering therapies for the treatment of gout
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
The renal urate transporter SLC17A1 locus: confirmation of association with gout
Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Hidden gout- Ultrasound findings in patients with musculo-skeletal problems and hyperuricemia
Susceptibility genes of hyperuricemia and gout
Lowering the risk of hyperuricemia and gout is associated with ideal cardiovascular health
Effects of worn and new footwear on plantar pressure in people with gout
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2
Adherence with urate-lowering therapies for the treatment of gout
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
The renal urate transporter SLC17A1 locus: confirmation of association with gout
Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Hidden gout- Ultrasound findings in patients with musculo-skeletal problems and hyperuricemia
Susceptibility genes of hyperuricemia and gout
Lowering the risk of hyperuricemia and gout is associated with ideal cardiovascular health
Effects of worn and new footwear on plantar pressure in people with gout
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2
Adherence with urate-lowering therapies for the treatment of gout
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
The renal urate transporter SLC17A1 locus: confirmation of association with gout
Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Hidden gout- Ultrasound findings in patients with musculo-skeletal problems and hyperuricemia
Susceptibility genes of hyperuricemia and gout
Lowering the risk of hyperuricemia and gout is associated with ideal cardiovascular health
Effects of worn and new footwear on plantar pressure in people with gout